Largest pharmaceutical companies in the United States by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

AbbVie leads the 24 pharmaceutical companies in the United States ranked by total debt, at R$400.9B, ahead of Pfizer (R$384.8B) and Merck & Co (R$292.8B). Figures as of 19 Nov 2026, 01:19 UTC, from the last saved Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AbbVieR$400.9B
Median
R$13.6B
Combined market value
R$22.61T
Countries
1
Not ranked
20no total debt on file

Live prices could not be loaded just now. Market values below are the last saved, from .

United States
All sectors
Pharmaceuticals
BRL
Clear filters
Largest pharmaceutical companies in the United States by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AbbVieABBV · Health CareR$400.9BR$3TR$1,698.58 2.33% down 26% up United States
2PfizerPFE · Health CareR$384.8BR$949.9BR$166.65 1.44% down 14% up United States
3Merck & CoMRK · Health CareR$292.8BR$2.02TR$818.26 3.90% down 51% up United States
4Johnson & JohnsonJNJ · Health CareR$284.7BR$3.9TR$1,619.54 2.15% down 38% up United States
5Bristol-Myers SquibbBMY · Health CareR$267.9BR$723BR$353.72 2.92% down 34% up United States
6Eli LillyLLY · Health CareR$252.4BR$7.31TR$8,212.01 2.32% down 35% up United States
7ViatrisVTRS · Health CareR$85.6BR$138.1BR$120.44 0.83% down 96% up United States
8Abbott LaboratoriesABT · Health CareR$76.8BR$1.07TR$620.50 0.22% down 17% down United States
9ZoetisZTS · Health CareR$53.7BR$206.5BR$508.19 2.50% up 29% down United States
10Royalty PharmaRPRX · Health CareR$53.2BR$234.5BR$407.82 0.01% down 78% up United States
11Elanco Animal HealthELAN · Health CareR$23.9BR$79.3BR$158.57 3.29% up 20% up United States
12Amneal PharmaceuticalsAMRX · Health CareR$15.3BR$45.3BR$129.94 3.60% up 83% up United States
13BridgeBio PharmaBBIO · Health CareR$11.9BR$90.2BR$463.29 1.58% up 17% up United States
14Regeneron PharmaceuticalsREGN · Health CareR$11.8BR$580.9BR$5,615.41 1.28% down 36% up United States
15Ionis PharmaceuticalsIONS · Health CareR$10.8BR$27.1BR$162.67 1.59% up 64% down United States
16InsmedINSM · Health CareR$3.2BR$156.1BR$711.48 1.69% down 40% down United States
17Madrigal PharmaceuticalsMDGL · Health CareR$2BR$54.9BR$2,364.16 5.67% down 24% down United States
18Legend BiotechLEGN · Health CareR$1.9BR$18.7BR$96.51 0.87% up 42% down United States
19CytokineticsCYTK · Health CareR$1.7BR$42.5BR$304.78 0.64% down 20% down United States
20TG TherapeuticsTGTX · Health CareR$1.5BR$59.4BR$392.68 5.44% up 107% up United States
21Cogent BiosciencesCOGT · Health CareR$1.3BR$28.7BR$165.16 0.14% down 20% down United States
22Axsome TherapeuticsAXSM · Health CareR$1.1BR$41.9BR$795.81 1.43% down 7% down United States
23Rhythm PharmaceuticalsRYTM · Health CareR$642.5MR$49BR$706.97 2.08% up 13% up United States
24Definium TherapeuticsDFTX · Health CareR$241MR$23.7BR$172.94 0.88% down 169% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 5.9389 BRL). 20 companies have no total debt on file and are not ranked here.

Questions and answers

Which pharmaceutical companies in the United States rank first by total debt?

AbbVie (R$400.9B), Pfizer (R$384.8B) and Merck & Co (R$292.8B) are the top three of the 24 pharmaceutical companies in the United States ranked by total debt as of 19 Nov 2026, 01:19 UTC.

How many pharmaceutical companies in the United States are in this ranking?

24 are ranked by total debt. 20 more have no total debt on file and are left out rather than ranked at zero.

What are these pharmaceutical companies in the United States worth together?

The 24 pharmaceutical companies in the United States ranked by total debt have a combined market value of R$22.61T as of 19 Nov 2026, 01:19 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United States by total debt”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.